Skye Bioscience to discontinue development of eye disease treatment-March 2024-www.financetom.com

Skye Bioscience to discontinue development of eye disease treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Skye Bioscience to discontinue development of eye disease treatment

Jun 10, 2024 4:51 AM

June 10 (Reuters) - Skye Bioscience ( SKYE ) said on

Monday it intends to discontinue development of its experimental

eye disease treatment after it failed in a mid-stage study.

Previous page： Vertex Expects Higher Q1 Revenue, Plans $250 Million Notes Offering Next page： Centuri Closes Initial Public Offering

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vertex Expects Higher Q1 Revenue, Plans $250 Million Notes Offering

Apr 22, 2024

05:58 PM EDT, 04/22/2024 (MT Newswires) -- Vertex (VERX) said late Monday it expects Q1 revenue of between $155.5 million and $157.5 million, up from $132.8 million a year earlier. Analysts polled by Capital IQ expect $154.4 million. The company will release its Q1 results on May 8. Vertex also said it plans to raise $250 million via a private...

Centuri Closes Initial Public Offering

Apr 22, 2024

05:52 PM EDT, 04/22/2024 (MT Newswires) -- Centuri Holdings ( CTRI ) said late Monday it closed its initial public offering of 14.26 million shares at $21 apiece, including the exercise in full of over-allotment option. Centuri ( CTRI ) shares began trading on the New York Stock Exchange on April 18. Southwest Gas Holdings ( SWX ) is the...

UnitedHealth says hack could impact data of 'substantial proportion' of Americans

Apr 22, 2024

April 22 (Reuters) - UnitedHealth Group ( UNH ) said on Monday the cyberattack at its technology unit led to a breach of health and personal information, which could cover a 'substantial proportion' of Americans. The company, however, did not disclose the number of people impacted by the February cyberattack at the Change Healthcare division. It said it would take...

Lufax Reports Q1 Loss, Lower Total Income; New CFO Named

Apr 22, 2024

06:03 PM EDT, 04/22/2024 (MT Newswires) -- Lufax Holding ( LU ) reported a Q1 loss late Monday of 1.52 Chinese renminbi ($0.21) per diluted American depositary share, compared with earnings of 1.18 renminbi a year earlier. Each ADS represents two ordinary shares. Total income for the quarter ended March 31 fell to 6.96 billion renminbi from 10.08 billion renminbi...